4893 items matching your search terms.

Clinical trial design and management: the role of PPAR-alpha agonists in prevention of CVD

Keech, AC Simes, RJ FIELD Study Investigators,

Fenofibrate and cardiovascular events in patients with type 2 diabetes: Commentary

Keech, A. Simes, R. J. Barter, P. Horng, M. S.

Effects of long-term fenofibrate therapy in the FIELD study

Keech, A.C.

Fenofibrate Intervention and Event Lowering in Diabetes: FIELD study

Keech, A.C.

Role of PPAR-alpha agonists in diabetic disease

Keech, A.C.

Metabolic syndrome and diabetes

Keech, A.C.

To manage diabetes: management in the early stages

Keech, A.C.

New efficacy and safety data in the FIELD study

Keech, A.C.

The FIELD study: authors' reply [letter]

Keech, A; Simes, RJ; Barter, P; Best, J; Scott, R; Taskinen, MR; and for the FIELD Study Investigators,

Risk factors for 10-year coronary mortality in patients with prior acute coronary syndromes: the LIPID cohort. The LIPID Study Investigators

Kirby, A; Simes, J; Pater, H; Keech, A; Hunt, D; White, H; West, M; Nestel, P; Tonkin, A; for the LIPID Study Investigators,

Presenting symptoms of epithelial ovarian cancer

Lataifeh, I.M. Marsden, D.E. Roberston, G. Gebski, V. Hacker, N. F.

Is a stable disease according to RECIST criteria a real stable disease in GIST patients treated with imatinib mesylate included in the intergroup EORTC/ISG/AGITG trial?

Le Cesne, A Van Glabbeke, M Verweij, J Casali, P Zalcberg, J Reichardt, P Issels, RD Judson, IR Blay, JY

Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project protocol C-06

Lembersky, BC Wieand, HS Petrelli, NJ O'Connell, MJ Colangelo, LH Smith, RE Seay, TE Giguere, JK Marshall, ME Jacobs, AD Colman, LK Soran, A Yothers, G Wolmark, N
JOURNAL OF CLINICAL ONCOLOGY, 2006     DOI:10.1200/jco.2005.04.7498

Prospective registry of reperfusion therapy for ST elevation acute coronary syndromes in part of hospitals in China

Litian, Y Jun, Z Mister, R Yan, Z Jiandong, L Duolao, W Lisheng, L Flather, M

When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?

Lord, S.J. Irwig, L. Simes, R.J.